Zobrazeno 1 - 10
of 531
pro vyhledávání: '"Aarden L"'
Publikováno v:
British Journal of Pharmacology. Nov2003, Vol. 140 Issue 5, p980-986. 7p. 6 Graphs.
Publikováno v:
Clinical & Experimental Immunology. May1993, Vol. 92 Issue 2, p225-231. 7p.
Autor:
Mierlo, G.J.D. van, Cnubben, N.H.P., Wouters, D., Wolbink, G.J., Hart, M.H.L., Rispens, T., Ganderup, N.C., Kuper, C.F., Aarden, L., Penninks, A.H.
Publikováno v:
Journal of Immunotoxicology, 1, 11, 62-71
Immunogenicity is a major issue of concern for monoclonal antibodies used in human diseases and is by default mainly determined in non-human primates (NHP), as target molecules are considered most similar in NHP compared to human. In this manuscript
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8c5f4daad3eb3ab1629fc50cb9c46871
http://resolver.tudelft.nl/uuid:ca660385-2196-4ed1-a4f3-384dd6ba9502
http://resolver.tudelft.nl/uuid:ca660385-2196-4ed1-a4f3-384dd6ba9502
Autor:
Aarden, L.1 l.aarden@sanquin.nl
Publikováno v:
Scandinavian Journal of Immunology. Jul2005 Supplement 1, Vol. 62, p33-35. 3p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Progress in inflammation research
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::72e75ea9f2b76f4574eec9562c338ef1
https://pure.amc.nl/en/publications/genetic-regulation-of-interleukin13-production(2c4800c4-1b90-4611-a002-f610b6751de6).html
https://pure.amc.nl/en/publications/genetic-regulation-of-interleukin13-production(2c4800c4-1b90-4611-a002-f610b6751de6).html
Autor:
van Lopik, T., Bijl, M., Hart, M., Boeije, L., Gesner, T., Creasy, A. A., Kallenberg, C. G., Aarden, L. A., Smeenk, R. J.
Publikováno v:
Journal of rheumatology, 26(1), 60-67. Journal of Rheumatology
We related soluble Fas (sFas) levels to the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) in a longitudinal series of plasma samples of patients with SLE to evaluate the relation between excessive production of sFas and disease activit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::454f7c7f8fca193a352d07e0d3b0d010
https://pure.amc.nl/en/publications/patients-with-systemic-lupus-erythematosus-with-high-plasma-levels-of-sfas-risk-relapse(e4c5c40b-3811-422a-8ba1-bf52f53b8871).html
https://pure.amc.nl/en/publications/patients-with-systemic-lupus-erythematosus-with-high-plasma-levels-of-sfas-risk-relapse(e4c5c40b-3811-422a-8ba1-bf52f53b8871).html
Publikováno v:
Blood, 91, 1464-1468
Scopus-Elsevier
Annemarie van Nieuwenhuijze
Europe PubMed Central
Scopus-Elsevier
Annemarie van Nieuwenhuijze
Europe PubMed Central
Graft-versus-host disease (GVHD) and infections are two major complications of allogeneic bone marrow transplantation (BMT). In the course of GVHD, one of the pathways that activated cytotoxic T cells use to execute their killing mechanisms is the Fa
Autor:
van Zaanen, H. C., Lokhorst, H. M., Aarden, L. A., Rensink, H. J., Warnaar, S. O., van der Lelie, J., van Oers, M. H.
Publikováno v:
British journal of haematology, 102(3), 783-790. Wiley-Blackwell
Interleukin 6 plays a key role in the pathogenesis of multiple myeloma (MM). Therefore we conducted a phase I dose-escalating study with chimaeric monoclonal anti-IL6 antibodies (cMab) in MM patients resistant to second-line chemotherapy. The cMab (C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::feee71a7cb2c97d7d7a763c085239f28
https://pure.amc.nl/en/publications/chimaeric-antiinterleukin-6-monoclonal-antibodies-in-the-treatment-of-advanced-multiple-myeloma-a-phase-i-doseescalating-study(4ae276b4-5459-4de1-acd6-d8d60f2a4be0).html
https://pure.amc.nl/en/publications/chimaeric-antiinterleukin-6-monoclonal-antibodies-in-the-treatment-of-advanced-multiple-myeloma-a-phase-i-doseescalating-study(4ae276b4-5459-4de1-acd6-d8d60f2a4be0).html